As the US approaches its first manned mission to the moon in more than five decades, private firms like SpaceX,…
McAlinden Research PartnersMarch 29, 2023
Saudi Arabia's seven-year diplomatic freeze and proxy conflict with Iran appears to have come to an end after China brokered…
McAlinden Research PartnersMarch 16, 2023
Pfizer's acquisition of Seagen, which is the largest biopharma deal since 2019, comes as products received in previous deals begin…
McAlinden Research PartnersMarch 14, 2023
Gold prices have shrugged off chaos in equity and bond markets over the last week, rallying back above $1900.00. While…
McAlinden Research PartnersMarch 13, 2023
Later today, President Biden will propose a federal budget allocation for the fiscal year 2024. Among other line items, the Space…
McAlinden Research PartnersMarch 9, 2023
As relations between Russia and most of the western world have been irreparably severed over the last year, Moscow's economic cooperation and…
McAlinden Research PartnersFebruary 28, 2023
A potential acquisition of Seagen by Pfizer, likely in the neighborhood of $40.0 billion, would be the biggest biopharma deal…
McAlinden Research PartnersFebruary 27, 2023
Gold has shed most of its gains for the year in February, as some have begun to speculate that the Fed could…
McAlinden Research PartnersFebruary 23, 2023
Almost one year on from Russia's formal invasion of Ukraine, all sides seem committed to staying the course and fighting…
McAlinden Research PartnersFebruary 21, 2023
